Omnipaque 350

See also: Generic Omnipaque 140, Generic Omnipaque 180, Generic Omnipaque 240, Generic Omnipaque 300

Omnipaque 350 is a brand name of iohexol, approved by the FDA in the following formulation(s):

OMNIPAQUE 350 (iohexol - solution; injection, oral)

• 
  Manufacturer: GE HEALTHCARE
  
  Approval date: December 26, 1985
  
  Strength(s): 75.5% ^[RLD]


• 
  Manufacturer: GE HEALTHCARE
  
  Approval date: October 24, 1995
  
  Strength(s): 75.5%
  

Has a generic version of Omnipaque 350 been approved?

No. There is currently no therapeutically equivalent version of Omnipaque 350 available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omnipaque 350. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Omnipaque 350.

See also...